111 related articles for article (PubMed ID: 22502706)
1. Lymphoproliferative disorders in multiple primary cancers.
Demirci U; Ozdemir N; Benekli M; Babacan NA; Cetin B; Baykara M; Coskun U; Zengin N; Buyukberber S
Asian Pac J Cancer Prev; 2012; 13(1):383-6. PubMed ID: 22502706
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.
Watanabe M; Kanda J; Hishizawa M; Nishikori M; Kondo T; Yamashita K; Takaori-Kondo A
Ann Hematol; 2020 Jul; 99(7):1565-1573. PubMed ID: 32436013
[TBL] [Abstract][Full Text] [Related]
3. Cancer Therapy-associated Lymphoproliferative Disorders: An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder.
Pina-Oviedo S; Miranda RN; Medeiros LJ
Am J Surg Pathol; 2018 Jan; 42(1):116-129. PubMed ID: 29112013
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review.
Marchetti M; Carobbio A; Capitoni E; Barbui T
Am J Hematol; 2018 May; 93(5):698-703. PubMed ID: 29377227
[TBL] [Abstract][Full Text] [Related]
5. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.
Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
Transplantation; 2004 Feb; 77(3):431-7. PubMed ID: 14966421
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disease detected by breast cancer screening.
Luttwak E; Segman Y; Saban M; Gutwein O; Avivi I; Perry C; Filiavich A; Sarid N
J Med Screen; 2022 Dec; 29(4):255-259. PubMed ID: 35818749
[TBL] [Abstract][Full Text] [Related]
8. The results of modern surgical therapy for multiple primary lung cancers.
Adebonojo SA; Moritz DM; Danby CA
Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with sporadic colorectal cancer and primary cancers of other organs.
Kan JY; Hsieh JS; Pan YS; Wang WM; Chen FM; Jan CM; Huang YS; Huang TJ; Wang JY
Kaohsiung J Med Sci; 2006 Nov; 22(11):547-53. PubMed ID: 17110343
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD
Br J Haematol; 2007 Nov; 139(3):398-404. PubMed ID: 17910629
[TBL] [Abstract][Full Text] [Related]
11. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
[TBL] [Abstract][Full Text] [Related]
12. [Synchronous and metachronous myeloid and lymphoid tumors].
Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
[TBL] [Abstract][Full Text] [Related]
13. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
[TBL] [Abstract][Full Text] [Related]
14. Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis.
Liu YY; Chen YM; Yen SH; Tsai CM; Perng RP
Lung Cancer; 2002 Feb; 35(2):189-94. PubMed ID: 11804692
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary malignant neoplasms: multi-center results from Turkey.
Babacan NA; Aksoy S; Cetin B; Ozdemir NY; Benekli M; Uyeturk U; Ali Kaplan M; Kos T; Karaca H; Oksuzoglu B; Zengin N; Buyukberber S
J BUON; 2012; 17(4):770-5. PubMed ID: 23335539
[TBL] [Abstract][Full Text] [Related]
16. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
18. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.
Hoshida Y; Tomita Y; Zhiming D; Yamauchi A; Nakatsuka S; Kurasono Y; Arima Y; Tsudo M; Shintaku M; Aozasa K
Int J Cancer; 2004 Jan; 108(3):443-9. PubMed ID: 14648712
[TBL] [Abstract][Full Text] [Related]
20. [Colorectal cancer in the context of multiple primary malignant neoplasms].
García-Anguíano F; Marchena Gómez J; Aguiar Morales JA; Gómez Guerra G; Conde Martel A; Cruz Benavides F
Rev Esp Enferm Dig; 1995 May; 87(5):369-74. PubMed ID: 7626296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
